Crossref
Comparison of a Novel Blood-Based Hemato-Immune Response Score (HIRS) with IMDC and MSKCC Models in Metastatic Renal Cell Carcinoma
Eurasian Journal of Medical Investigation · 2026 · 18-24
DOI: 10.14744/ejmi.263018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Medical Investigation, 2026. Verfasst von Mustafa Ersoy.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ersoy, M. (2026). Comparison of a Novel Blood-Based Hemato-Immune Response Score (HIRS) with IMDC and MSKCC Models in Metastatic Renal Cell Carcinoma. Eurasian Journal of Medical Investigation, 18-24. https://doi.org/10.14744/ejmi.263018
Vancouver
Ersoy M. Comparison of a Novel Blood-Based Hemato-Immune Response Score (HIRS) with IMDC and MSKCC Models in Metastatic Renal Cell Carcinoma. Eurasian Journal of Medical Investigation. 2026:18-24. doi:10.14744/ejmi.263018
BibTeX
@article{Ersoy2026,
author = {Ersoy, Mustafa},
title = {Comparison of a Novel Blood-Based Hemato-Immune Response Score (HIRS) with IMDC and MSKCC Models in Metastatic Renal Cell Carcinoma},
journal = {Eurasian Journal of Medical Investigation},
year = {2026},
pages = {18--24},
doi = {10.14744/ejmi.263018}
}
EUVIMED